Hybrid cells, prepared by fusion of autologous myeloma cells and dendritic cells, induced MHC restricted myeloma-specific cytolytic T cells, which could not be obtained by using the patients' tumor cells alone or DC alone (21). This evidence concerns the gene HLA-C and neoplasm.